Table 8.
Fatty acids | Dietary treatments1) | SEM | ||||
---|---|---|---|---|---|---|
| ||||||
Control | CM | CMEnz | CMPh | CMEnzPh | ||
Myristic (C14:0) | 0.37a | 0.29b | 0.27c | 0.29b | 0.29b | 0.01 |
Myristoleic (C14:1c9) | 0.07a | 0.03b | 0.02b | 0.00b | 0.01b | 0.01 |
Pentadecylic (C15:0) | 0.08 | 0.08 | 0.07 | 0.09 | 0.08 | 0.01 |
Palmitic (C16:0) | 23.86a | 21.08c | 21.18bc | 22.07b | 21.86bc | 0.24 |
Palmitoleic (C16:1) | 4.65a | 2.58b | 2.35b | 1.80c | 2.46b | 0.24 |
Margaric (C17:0) | 0.94 | 0.96 | 1.05 | 1.29 | 0.93 | 0.09 |
Heptadecenoic (C17:1) | 0.06 | 0.14 | 0.19 | 0.09 | 0.14 | 0.07 |
Stearic acid (C18:0) | 8.01c | 8.09c | 9.07b | 9.84a | 8.39b | 0.42 |
Oleic (C18:1) | 30.43a | 26.72b | 26.28b | 25.36c | 26.67b | 0.77 |
Vaccenic (C18:1, 7) | 4.54a | 4.39b | 4.39b | 4.07c | 4.27b | 0.09 |
Nonoadecanoic (C19:0) | 0.47 | 0.48 | 0.53 | 0.66 | 0.46 | 0.05 |
Linoleic (C18:2, n-6) | 19.33c | 25.54a | 24.27a | 22.98b | 24.96a | 0.65 |
Arachidic (C20:0) | 0.04 | 0.05 | 0.04 | 0.04 | 0.03 | 0.01 |
α-Linolenic (C18:3 n-3) | 1.02d | 1.96a | 1.76b | 1.62c | 1.79b | 0.09 |
Heneicosanoic (C21:0) | 0.24 | 0.25 | 0.27 | 0.33 | 0.23 | 0.03 |
Eicosadienoic (C20:2, n-6) | 0.36c | 0.67a | 0.59b | 0.67a | 0.57b | 0.57 |
Eicosatrienoic (C20:3 n-6) | 0.03c | 0.10a | 0.09b | 0.11a | 0.07b | 0.01 |
Erucic (C22:1) | 0.83 | 0.76 | 0.75 | 0.84 | 0.70 | 0.07 |
Arachidonic (C20:4 n-6) | 3.72c | 4.39b | 5.25a | 5.94a | 4.69b | 0.49 |
Eicosopentaenoic C20:5 n-3) | 0.20 | 0.22 | 0.19 | 0.26 | 0.20 | 0.03 |
Docosapentaenoic (C22:5 n-3) | 0.32c | 0.63b | 0.69b | 0.81a | 0.62b | 0.06 |
Docosahexanoic (C22:6 n-3) | 0.18c | 0.38b | 0.46b | 0.61a | 0.37b | 0.06 |
SEM, standard error of the mean.
Dietary treatments: Control, commercial broiler diet; CM, 17.5% CM inclusion; CMEnz, 17.5% CM inclusion +0.3 g/kg Axtra XAP; CMPh, 17.5% CM inclusion+1.5% Potassium Humate; CMEnzPh, 17.5% CM inclusion+1.5% PH+0.3 g/kg Axtra XAP.
Means in the same row with different superscripts are significantly different (p<0.05).